![\"\"](\"https:\/\/uniquemedia.ie\/wp-content\/uploads\/2024\/01\/APC-VLE.jpg\")
<\/p>\n<\/p>\n
\u00a0<\/strong><\/p>\n \u00a0<\/strong><\/p>\n The Medicine Accelerator<\/em>, the Irish Multinational group responsible for breakthrough pharma process research and development (APC) and Manufacture (VLE), today announce a groundbreaking expansion that involves the creation of 300 new R&D jobs and a \u20ac100M capital expansion to form a globally unique Medicine Accelerator Campus<\/em> in Cherrywood Dublin.<\/p>\n The 130,000 sq ft campus, the largest R&D site in the biopharma sector in Ireland and the expanded home for APC & VLE, will integrate the latest developments in scientific research, AI, neural networks and scientifically led manufacturing activities. This value chain is transforming medicine development and the time to patient for new and advanced therapeutics.<\/p>\n Partnering with eight of the top 10 pharmaceutical companies globally and a wide range of biotechs, APC & VLE works across a wide range of therapeutic areas. The business is currently working on 35+ medicines that transform patient treatment in areas such as oncology, respiratory disease, Alzheimer\u2019s, HIV and more, at its HQ in Dublin.<\/p>\n Serving as a global research epicentre The Medicine Accelerator Campus<\/em> represents one of the most disruptive businesses in pharmaceutical development, digitalization and manufacturing. At its core, this disruption will be facilitated by three interwoven strategic elements:<\/p>\n The group, which is fully Irish owned, is already the largest employer of R&D scientists, within the pharmaceutical sector, nationally. This addition of 300 new roles will bring the combined team to over 600 scientists, digital experts, and manufacturing professionals bringing The Medicine Accelerator<\/em> team to a global stage.<\/p>\n This significant growth underscores the organisations dedication to fostering talent, and creating a powerhouse team to drive advancements in research, digital capabilities and manufacturing. The organisation has also developed iAchieve<\/em>, a cutting-edge digitalisation platform that meticulously digitizes every facet of a medicine’s development and manufacturing journey. This digital transformation is a step change in medicine R&D and presents huge opportunity for medicine acceleration through AI and other advanced digital applications.<\/p>\n Mark Barrett, CEO and Co-Founder of APC & VLE Therapeutics, <\/strong>says the expansion solidifies APC & VLE\u2019s commitment to advancing innovation in the global pharmaceutical industry.<\/p>\n \u201cReimagining how medicines are developed and accelerated to patients is our motivation, our purpose.<\/em> Today\u2019s announcement of an additional 300 new jobs, along with a \u20ac100 million capital plan to create a new 130,000 ft2<\/sup> Medicine Accelerator Campus in Cherrywood, Dublin, demonstrates our confidence in our team to deliver on that purpose. We are 100% behind them, they are simply extraordinary. As an Irish Multinational company, it also solidifies our confidence in the biopharma ecosystem in Ireland as a global hub, one that is trusted and central to medicine supply chains globally, to drive further innovation in the areas of pharmaceutical R&D, digitalization, and manufacture.<\/em><\/p>\n This new expansion will further strengthen our competitiveness through increased integration of the latest developments in sustainability, artificial intelligence, and breakthrough science. It will enable our team to reimagine and transform medicine development and manufacture. I am so excited to see our organization pursue such a patient focused mission. <\/em><\/p>\n The support of Enterprise Ireland has been pivotal in accelerating this expansion and we look forward to continuing to work with them on our mission to accelerate medicines to patients.\u201d<\/em><\/p>\n The expansion is being supported by Enterprise Ireland, who welcome the creation of high value pharma jobs and the strengthening of Ireland\u2019s position in the global value chain of medicine development and manufacturing.<\/p>\n Welcoming the announcement, Simon Coveney, Minister for Enterprise, Trade and Employment of Ireland, said:<\/strong><\/p>\n ”I want to congratulate Mark and his team at APC <\/em>& VLE on today\u2019s landmark announcement.\u00a0 The new Medicine Accelerator Campus demonstrates the capacity of Irish-owned businesses to become world leaders in their field, bringing together technology, innovation and ambition to make a real difference in people\u2019s lives across the globe.<\/em><\/p>\n \u201cThe government through Enterprise Ireland is committed to scaling and building globally impactful Irish Multinationals that will help drive the Irish economy forward and create high value jobs at home. APC <\/em>& VLE’s announcement today is testament to that Irish Multinational ambition in action and I am delighted to support them on their patient-focused mission.”<\/em><\/p>\n Leo Clancy, CEO of Enterprise Ireland, said<\/strong>:<\/em><\/p>\n \u201cEnterprise Ireland is proud to support the ambitious vision behind APC <\/em>& VLE\u2019s groundbreaking Medicine Accelerator Campus announced today.\u00a0 The Campus will further enhance Ireland\u2019s global reputation as a leader in the Life Sciences sector and I want to congratulate the entire team at APC <\/em>& VLE on delivering on this remarkable project.<\/em><\/p>\n \u201cOne of Enterprise Ireland\u2019s core priorities is to assist Irish owned companies to scale internationally, while creating high-value jobs at home.\u00a0 Today\u2019s announcement is a concrete example of how this can be achieved and we look forward to continuing to work closely with APC <\/em>& VLE as they implement their ambitious strategy and delivering innovative health solutions to a global market.\u201d<\/em><\/p>\n\n
\n
\n